$LCTX
Lineage Cell Therapeutics, Inc.
XASE
Why is LCTX down today? It is at $1.08 (-1.82%), and our scanner flagged it 16 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment LCTX spikes, and full due diligence on LCTX — key stats, earnings, dilution and insider activity. Free.
Get free $LCTX alerts the moment volume spikes
Our scanner flagged $LCTX 16 times in the last 30 days. Create a free account to track $LCTX, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
Key Stats
- Price
- $1.08
- Change today
- -1.82%
- Previous close
- $1.10
- 52-week range
- $1.00 – $2.09
- Market cap
- $278M
- Institutional own.
- 51.72%
- Total held
- 77.6%
- Tradeable float
- 56.8M 22% of shares · after 26% insiders + 52% institutions
- Short interest
- 28.3M ▼ -4% vs prior · as of 2026-08-14
- Short % of float
- 49.9%
- Days to cover
- 35.1d
- Avg daily volume
- 1.4M
- Exchange
- XASE
- 5m
- 0.4x
- 15m
- 0.4x
- 1h
- 0.9x
- 1D
- --
Get free LCTX + market alerts in your inbox
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Why is $LCTX down today?
Here is the latest on LCTX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for LCTX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystLineage Cell Therapeutics, Inc.: Q2 FY2026 results, three months to Jun 30, 2026, from the latest SEC filing. Read it →Analyst data via Nasdaq. Not investment advice.
Insiders
1 open-market buy0 buys, 0 sells last 3 months (3/4 over 12 months)Show 12 recent transactionsMinimize 12 recent transactions
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Culley Brian M Officer | Bought (open market) | +15K | added 6.2% | 256K | $24K at $1.62 | Mar 12, 26 |
Culley Brian M Officer | Sold (automatic/other) | -13K | sold 5.1% | 241K | $23K at $1.80 | Feb 11, 26 |
Culley Brian M Officer | Other | 31K 0.01% of company | added 14% | 253K | n/a | Feb 11, 26 |
Samuel George A. Iii Officer | Sold (automatic/other) | -3K | sold 7.5% | 31K | $5K at $1.80 | Feb 11, 26 |
Samuel George A. Iii Officer | Other | 6K | added 22% | 34K | n/a | Feb 11, 26 |
Samuel George A. Iii Officer | Acquired (grant/award) | +2K | added 6.7% | 28K | n/a | Dec 19, 25 |
Samuel George A. Iii Officer | Sold (automatic/other) | -65 | sold 0.2% | 27K | $109 at $1.68 | Dec 19, 25 |
Culley Brian M Officer | Acquired (grant/award) | +9K | added 4.2% | 222K | n/a | Dec 19, 25 |
Culley Brian M Officer | Sold (automatic/other) | -334 | sold 0.2% | 222K | $561 at $1.68 | Dec 19, 25 |
Culley Brian M Officer | Sold (automatic/other) | -13K | sold 5.5% | 214K | $8K at $0.650 | Feb 11, 25 |
Culley Brian M Officer | Other | 31K 0.01% of company | added 16% | 226K | n/a | Feb 11, 25 |
Samuel George A. Iii Officer | Sold (automatic/other) | -2K | sold 8.6% | 26K | $2K at $0.650 | Feb 11, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Dilution watch
Active shelfRecent share offering + active shelf on file — the company raised capital and can raise more. If $LCTX runs, these filings show who may be positioned to sell new or newly-registered shares into the move.
- 60,000,000 new shares
- At-the-market (ATM) program — sells new shares into the market gradually over time · About $100.0M in size
Sourced from SEC EDGAR filings (last 9 months); terms read straight from the filing text where available. Ongoing = an at-the-market (ATM) program still selling over time or a live shelf, so it can keep diluting; Completed = a one-time priced sale that already finished. A shelf (S-3) stays effective ~3 years. Form type signals dilution capacity, not an exact share count, and we can't confirm how much of a shelf or ATM remains unused. Not investment advice.
$LCTX Sentiment
BullishBlend of news sentiment, today’s move, and community votes. Not investment advice.
$LCTX Activity
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
LCTX stock FAQ
Why is $LCTX down today?
Here is the latest on LCTX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for LCTX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
What is the LCTX stock price today?
LCTX last traded at $1.08, down 1.82% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Where can I see live LCTX alerts?
The LCTX Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged LCTX 16 times in the last 30 days.
What exchange is LCTX on?
LCTX (Lineage Cell Therapeutics, Inc.) trades on XASE, with a market cap of about $278M.
Is LCTX good for day trading?
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge LCTX for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.